Facebook X-twitter Linkedin

AIFA Procedure

AIFA (Italian Drug Agency) is the national authority responsible for the regulation of pharmaceutical products in Italy.

For the ESPEN 2027 Congress only Italian pharmaceutical companies attending or supporting the event through any form of sponsorship are required to obtain authorization from AIFA, as per Italian law (Decreto Legislativo 219/06, art. 124). Non-Italian pharmaceutical companies are not required to follow this procedure.

According to Italian law, this authorization process for Italian companies must be managed by an Italian agency. FARGO INTERNATIONAL has been appointed as the preferred agency to support Italian sponsors and exhibitors with AIFA-related procedures for the congress.

Contact Information

Fargo International di Giulia Cambria
Via Pietro Maroncelli, 32
50137 Firenze, Italy
Email: info@fargointernational.it

Important Deadlines

21/06/2027 – Deadline for the Italian Official Agency to upload the application (pre-request) on the AIFA website.

11/07/2027 – Final deadline for pharmaceutical companies to complete and validate the application on the AIFA website.

Abstract submissions open 8 January 2027

LEARN MORE

Be aware of unauthorised agencies

Companies unrelated to ESPEN are using our brand, pretending to provide official services on websites. They are not mandated by ESPEN.

The official registration and housing bureau for the ESPEN 2027 Congress is MCI Suisse SA.

Contact: espenR@mci-group.com.

Get The Latest Updates

You can unsubscribe at any time by clicking the link in the footer of our emails. For information about our privacy practices, please visit our website. MCI Group collects your personal data to submit information related to ESPEN 2027. For more information, see the privacy statements for both ESPEN and MCI.

MCI Group collects your personal data to submit information related to ESPEN. For more information: Privacy Statement.

PLEASE NOTE: ESPEN does not sell your personal data. ESPEN might send you emails with carefully selected sponsored content from partners whose support helps us deliver and subsidise key activities for our community. These messages may include relevant updates on innovations, products, and activities linked to ESPEN events and the wider field of clinical nutrition and metabolism. Your subscription to the newsletter via the form gives us consent to send you these selected sponsored communications.